KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Net Income (2016 - 2025)

Historic Net Income for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to -$6.8 million.

  • Fulgent Genetics' Net Income rose 5366.14% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.2 million, marking a year-over-year increase of 7248.56%. This contributed to the annual value of -$43.8 million for FY2024, which is 7324.35% up from last year.
  • Fulgent Genetics' Net Income amounted to -$6.8 million in Q3 2025, which was up 5366.14% from -$19.2 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Net Income high stood at $200.7 million for Q1 2021, and its period low was -$122.9 million during Q4 2023.
  • Moreover, its 5-year median value for Net Income was -$9.1 million (2024), whereas its average is $21.0 million.
  • Per our database at Business Quant, Fulgent Genetics' Net Income surged by 1185694.2% in 2021 and then crashed by 110268.06% in 2023.
  • Fulgent Genetics' Net Income (Quarter) stood at $103.7 million in 2021, then crashed by 123.22% to -$24.1 million in 2022, then plummeted by 410.33% to -$122.9 million in 2023, then skyrocketed by 94.95% to -$6.2 million in 2024, then dropped by 9.66% to -$6.8 million in 2025.
  • Its Net Income stands at -$6.8 million for Q3 2025, versus -$19.2 million for Q2 2025 and -$11.9 million for Q1 2025.